Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Sales | 4,742,000 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1,199,000 | N/A | N/A | N/A | N/A |
| Gross Profit | 3,543,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 2,457,000 | 0 | 0 | 0 | 0 |
| Operating Income | 1,086,000 | N/A | N/A | N/A | N/A |
| Other Income | 216,000 | 0 | 0 | 0 | 0 |
| Pre-tax Income | 1,302,000 | 0 | 0 | 0 | 0 |
| Income Tax | 237,000 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 1,065,000 | N/A | N/A | N/A | N/A |
| Minority Interests | 1,000 | N/A | N/A | N/A | N/A |
| Net Income | $1,064,000 | $N/A | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | 0.42 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.42 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.42 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.42 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,305,000 | $N/A | $N/A | $N/A | $N/A |